LinXis Biopharmaceuticals
www.linxispharmaceuticals.comWe designed Fibrobodies®. These proprietary proteins bind selectively to so-called activated myofibroblasts in any type of fibrotic tissue. Fibrobodies® support conjugation of a wide range of payloads to create Fibrobody®-drug Conjugates. We are developing a line-up of Fibrobody®-drug conjugates for the diagnosis and treatment of fibrosis of the liver, kidney, lung and gut.
Read more
We designed Fibrobodies®. These proprietary proteins bind selectively to so-called activated myofibroblasts in any type of fibrotic tissue. Fibrobodies® support conjugation of a wide range of payloads to create Fibrobody®-drug Conjugates. We are developing a line-up of Fibrobody®-drug conjugates for the diagnosis and treatment of fibrosis of the liver, kidney, lung and gut.
Read more
Country
City (Headquarters)
Amsterdam
Industry
Employees
11-50
Founded
2012
Social
Employees statistics
View all employeesPotential Decision Makers
Founder and Consultant
Email ****** @****.comPhone (***) ****-****Head of Pharmaceutical Development
Email ****** @****.comPhone (***) ****-****Laboratory Technician
Email ****** @****.comPhone (***) ****-****
Technologies
(14)
We'll help you understand if Lusha can solve your business needs.
